Chapter 9 Medical Aspects of the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: 5-Alpha Reductase Inhibitors
Cavallo J, Kaplan S. Chapter 9 Medical Aspects of the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: 5-Alpha Reductase Inhibitors. 2018, 189-206. DOI: 10.1016/b978-0-12-811397-4.00009-3.Peer-Reviewed Original ResearchMaximum urinary flow rateInitial prostate volumeAcute urinary retentionUrinary flow rateProstate volumeUrinary retentionClinical progressionSymptom scoresLower Urinary Tract Symptoms/Benign Prostatic HyperplasiaUrinary tract symptoms/benign prostatic hyperplasiaAlpha-1 adrenergic receptor blockerLower urinary tract symptomsReductase inhibitorsAlpha-1 adrenergic receptorsSpecific antigen valuesPostvoid residual volumeSexual side effectsUrinary tract symptomsAdrenergic receptor blockersBenign prostatic hyperplasiaLong-term treatmentConversion of testosteroneHigher initial PSAEpithelial cell apoptosisReceptor blockers